Steven Cohen's AVDL Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 279,525 shares of Avadel Pharmaceuticals plc (AVDL) worth $6.02 M, representing 0.01% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in AVDL, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2023, adding 285,816 shares. Largest reduction occurred in Q3 2023, reducing 676,260 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Avadel Pharmaceuticals plc (AVDL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Avadel Pharmaceuticals plc (AVDL) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +279,525 | New Buy | 279,525 | $21.55 |
| Q3 2025 | -202,815 | Sold Out | 0 | $0.00 |
| Q2 2025 | +97,730 | Add 93.00% | 202,815 | $8.85 |
| Q1 2025 | +105,085 | New Buy | 105,085 | $7.83 |
| Q1 2024 | -285,816 | Sold Out | 0 | $0.00 |
| Q4 2023 | +285,816 | New Buy | 285,816 | $14.12 |
| Q3 2023 | -676,260 | Sold Out | 0 | $0.00 |
| Q2 2023 | +220,260 | Add 48.30% | 676,260 | $16.48 |
| Q1 2023 | +179,034 | Add 64.64% | 456,000 | $9.16 |
| Q4 2022 | +276,966 | New Buy | 276,966 | $7.16 |
Steven Cohen's Avadel Pharmaceuticals plc Investment FAQs
Steven Cohen first purchased Avadel Pharmaceuticals plc (AVDL) in Q4 2022, acquiring 276,966 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Avadel Pharmaceuticals plc (AVDL) for 10 quarters since Q4 2022.
Steven Cohen's largest addition to Avadel Pharmaceuticals plc (AVDL) was in Q4 2023, adding 285,816 shares worth $4.04 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 279,525 shares of Avadel Pharmaceuticals plc (AVDL), valued at approximately $6.02 M.
As of the Q4 2025 filing, Avadel Pharmaceuticals plc (AVDL) represents approximately 0.01% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Avadel Pharmaceuticals plc (AVDL) was 676,260 shares, as reported at the end of Q2 2023.